(Q45711962)

15 December 2017

title

Treatment of alcohol withdrawal with gabapentin (English)

1 reference

15 December 2017

0 references

Vasilis Bozikas

1

1 reference

15 December 2017

Petros Petrikis

2

1 reference

15 December 2017

Katerina Gamvrula

3

1 reference

15 December 2017

Ioanna Savvidou

4

1 reference

15 December 2017

Athanasios Karavatos

5

1 reference

15 December 2017

publication date

1 January 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

15 December 2017

published in

1 reference

15 December 2017

volume

26

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

197-199

1 reference

Treatment of alcohol withdrawal syndrome with gabapentin

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

An open label study of gabapentin in the treatment of acute mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

Gabapentin. Antiepileptic mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

Metabolism and excretion of mood stabilizers and new anticonvulsants

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

Gabapentin as a potential treatment for anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

Gabapentin as an adjunctive treatment in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2801%2900234-2

7 January 2021

10.1016/S0278-5846(01)00234-2

Identifiers

DOI

1 reference

15 December 2017

1 reference